Brief: Century Therapeutics Reports Full Year 2023 Financial Results

Century Therapeutics

14/03/2024 12:16

March 14 (Reuters) - Century Therapeutics Inc  IPSC.O :
    * CENTURY THERAPEUTICS REPORTS FULL YEAR 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
    * ENDED 2023 WITH CASH, CASH EQUIVALENTS, AND INVESTMENTS OF
$261.8 MILLION; CASH RUNWAY INTO 2026
    * ON TRACK TO INITIATE PHASE 1 CALIPSO-1 CLINICAL TRIAL IN
FIRST
HALF OF 2024
    * EXPECTS FULL YEAR GAAP OPERATING EXPENSES TO BE BETWEEN
$135
MILLION AND $145 MILLION

Source text for Eikon:  ID:nGNXc9dg5s 
Further company coverage:  IPSC.O 

 ((Reuters.Briefs@thomsonreuters.com;))